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Abstract
Osteosarcopenia is an increasingly recognized geriatric syndrome with a considerable prevalence which increases morbidity 
and mortality. Although osteosarcopenia is a result of age-related deterioration in muscle and bone, there are many risk fac-
tors that provoking osteosarcopenia. These risk factors should be considered by the clinicians to treat osteosarcopenia. We 
assessed the link between osteosarcopenia and conventional risk factors of cardiovascular diseases. This study was a cross-
sectional study that has been conducted within the framework of Bushehr Elderly Health (BEH) program stage II in which 
participants aged ≥ 60 years were included. Osteopenia/osteoporosis was defined as a t-score ≤  − 1.0 standard deviation below 
the mean values of a young healthy adult. We defined sarcopenia as reduced skeletal muscle mass plus low muscle strength 
and/or low physical performance. Osteosarcopenia was considered as the presence of both osteopenia/osteoporosis and sar-
copenia. We estimated the age-standardized prevalence of osteosarcopenia for men and women, separately. Using modified 
Poisson regression analysis, adjusted prevalence ratio (PR) with 95% CI was used to show the measure of associations in 
the final model. Among 2353 participants, 1205 (51.2%) were women. Age-standardized prevalence of osteosarcopenia was 
33.8 (95% CI 31.0–36.5) in men and 33.9 (30.9–36.8) in women. In both sexes, the inverse association was detected with 
body mass index and having osteosarcopenia (PR 0.84, 95% CI 0.81–0.88 in men and 0.77, 95% CI 0.74–0.80 in women). 
In both sexes, high-fat mass was positively associated with osteosarcopenia [PR 1.46 (95% CI 1.11–1.92) in men, and 2.25 
(95% CI 1.71–2.95) in women]. Physical activity had a significant inverse association in men (PR = 0.64, 95% CI 0.46, 0.88), 
but not in women. Diabetes was also showed a direct association with osteosarcopenia in men (PR 1.33, 95% CI 1.04–1.69). 
No associations were detected between the lipid profiles and osteosarcopenia. Results demonstrated a high prevalence of 
osteosarcopenia in both sexes suggesting a high disease burden in a rapidly aging country. Lifestyle and socioeconomic 
factors, as well as chronic diseases, were significantly associated with osteosarcopenia.
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Introduction
Osteosarcopenia is an increasingly recognized geriatric 
syndrome, defined by the presence of sarcopenia which 
is a gradual build-up of body fat and a resultant reduc-
tion in lean muscle mass and strength and also osteopenia/
osteoporosis. In an era with a globally growing elderly and 
frail population, the condition is receiving further atten-
tion as multiple large studies have linked both osteopenia 
and sarcopenia with morbidity and mortality in this age 
group [1–4].
There is plenty of evidence on the prevalence, risk fac-
tors, and outcomes of osteoporosis as well as a growing 
body of evidence on sarcopenia; however, only a limited 
number of publications are available on osteosarcopenia 
as a syndrome addressing the cross-talk between bone and 
muscle [5]. A few studies on the prevalence of osteosarco-
penia in different countries have reported the prevalence 
rates of 12.5% to 40% among different elderly populations 
[6].
In addition to weakness and disability, osteosarcopenia 
is linked with cardiovascular diseases (CVDs) and their 
associated risk factors such as hyperlipidemia, obesity, 
type 2 diabetes mellitus, and hypertension [7–10]. There 
is, however, some contradictory evidence rejecting such 
a direct association between CVD and osteosarcopenia 
[10–15]. Although these studies had their own limitations 
[16], they have warranted the necessity of more inves-
tigations to produce further evidence and help end the 
controversy.
In the present study, we analyzed the true link between 
osteosarcopenia and CVD risk factors in a large popula-
tion of elderly over 60 years old living in Bushehr, Iran. 
We used baseline data from the second stage of the Bush-
ehr Elderly Health (BEH) program, which was initiated in 
October 2015 [17].
Materials and Methods
Study Population
This cross-sectional study was conducted within the 
framework of BEH program being conducted since 2013. 
The BEH program is a prospective, population-based 
cohort aiming at determining the prevalence and risk fac-
tors of non-communicable diseases among a representa-
tive sample of the elderly urban population residing in 
Bushehr, southern Iran [18]. In stage II of the study, 2426 
participants aged ≥ 60 years were included to estimate 
the prevalence of musculoskeletal disorders, cognitive 
impairment, and their risk factors, while also evaluating 
the associations between these entities and certain out-
comes during future follow-ups. The rationale for and 
methodology was described in detail elsewhere [17]. The 
study was approved by the Research Ethics Committee of 
both Bushehr University of Medical Sciences and Endo-
crinology and Metabolism Research Institute. After an 
explanation of the study objectives and protocols, written 
informed consent was obtained from all participants.
Data Collection
Using a valid questionnaire, subjects were privately inter-
viewed by trained interviewers to collect information on 
sociodemographic status, lifestyle-associated factors, gen-
eral health, medical history, and medication use, as well as 
mental and functional health [17].
The height and weight of the participants were measured 
using a fixed stadiometer and a digital scale, with shoes 
removed and the participants wearing light clothing. Body 
mass index (BMI) was calculated as weight (kg) divided 
by squared height  (m2). All measurements were read to the 
nearest 0.1 cm. Following 15 min in the sitting position, two 
measurements of systolic and diastolic blood pressure were 
taken on the right arm, and the mean of the two measure-
ments was considered as the participant’s blood pressure.
Patients’ lipid profile and blood glucose were measured 
by assessing venous samples, drawn after overnight fasting. 
Using the enzymatic colorimetric method with cholesterol 
esterase and cholesterol oxidase, total cholesterol (TC) was 
determined. Details for the measurements of fasting plasma 
glucose (FPG), high-density lipoprotein (HDL-C), low-den-
sity lipoprotein cholesterol (LDL-C), and triglyceride (TG) 
were reported elsewhere [17].
Physical activity level was assessed by a validated ques-
tionnaire in which nine different metabolic equivalents of 
task (MET) levels were ranged on a scale from sleep/rest to 
high-intensity physical activities [19, 20].
Body composition was measured using dual X-ray 
absorptiometry (DXA, Discovery WI, Hologic, Inc., USA). 
Using this device, bone mineral density, fat mass, and mus-
cle mass were measured. The bone mineral density of the 
lumbar spine (L1–4) and total hip were measured in the cor-
rect position. Appendicular skeletal muscle mass (ASM) for 
each participant was derived as the sum of upper and lower 
limb muscle mass. The skeletal muscle mass index (SMI) 
was defined as ASM/height2 (kg/m2). Muscle strength was 
measured by handgrip strength, using a digital dynamom-
eter. The measurement was carried out three times for each 
hand, and maximum grip strength was calculated by taking 
the average of the highest measurement from both hands. 
Usual walking speed (m/s) on a 4.57-m course was used as 
an objective measure of physical performance.
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Definition of Terms
Osteopenia/ osteoporosis was defined using the WHO stand-
ard criteria of t-score less than − 1.0 standard deviation (SD) 
in either the femoral neck, lumbar spine, or total hip [21]. 
Sarcopenia was defined as reduced skeletal muscle mass plus 
low muscle strength and/or low physical performance [22, 
23]. In a recent study, reference data from a normative Ira-
nian population are available for detecting sarcopenia. Based 
on these data, the cut-off values for low SMI were 7.0 kg/m2 
and 5.4 kg/m2 among men and women, respectively [24].
The muscle strength was handgrip strength < 26 kg for 
men and < 18 kg for women; while the cut-off value for low 
physical performance was a usual walking speed < 0.8 m/s 
for both genders [23]. Using these cut-off points, sarcopenic 
individuals were identified. Therefore, osteosarcopenia has 
been defined as the presence of sarcopenia and osteopenia/
osteoporosis.
Type 2 diabetes mellitus was ascertained among par-
ticipants who had FPG ≥ 126 mg/dl or taking anti-diabetic 
medication. Hypertension was defined as SBP ≥ 140 mmHg 
or DBP ≥ 90 mmHg or taking any anti-hypertensive medica-
tions. Hypercholesterolemia was defined as TC ≥ 200 mg/dl, 
high LDL-C as > 110 mg/dl, low HDL-C as < 40 mg/dl for 
men and < 50 mg/dl for women, and hypertriglyceridemia 
as TG ≥ 150 mg/dl [25]. High-fat mass was outlined as total 
body percent fat > 30 for men and > 40 for women [26]. Cur-
rent smokers were defined as participants who were smoking 
cigarettes daily or occasionally as well as those who used 
water pipes or pipes. In addition, participants were grouped 
as low physical activity or active, according to the MET 
values [20, 27].
Statistical Analysis
The data were expressed as mean (± SD) for continuous and 
the percentage for categorical variables. The osteosarco-
penic and non-osteosarcopenic populations were compared 
for the baseline characteristics using Pearson’s χ2 test for 
the categorical and independent sample t-test for continu-
ous variables. All comparisons were conducted in men and 
women, separately. The prevalence of osteosarcopenia in 
different age groups was estimated in both sexes. The crude 
prevalence of osteosarcopenia in the whole population was 
estimated by sex. Direct standardization, using the popula-
tion distribution of Iranian census data of 2016, was used to 
measure the age-standardized prevalence rates in men and 
women. We assessed the association of potential cardiovas-
cular variables on osteosarcopenia by a modified Poisson 
regression model.
Age, education, smoking, physical activity, BMI, hyper-
tension, diabetes, hypercholesterolemia, hypertriglyceri-
demia, low HDL-C, high LDL-C, and high-fat mass were 
considered as the main set of variables. To select the best 
model from all possible subsets and avoid overfitting, best 
subset method with the Akaike Information Criterion (AIC) 
was used. The multi-collinearity between variables was 
checked and the adjusted prevalence ratio (Adjusted PR) 
with 95% CI was used as the measure of associations in the 
final model. We considered the p-values < 0.05 as statisti-
cally significant. Stata statistical package, release 14, was 
used to perform the statistical analyses.
Results
After excluding the participants with missing values for 
osteosarcopenia (N = 48), and having any kind of cancer 
(N = 25), a total of 2353 participants (1205 women) were 
included in the present study. In all, 1988 (84.5%) par-
ticipants had osteopenia/osteoporosis and sarcopenia was 
detected in 779 (33.3%) of the study population. Osteosar-
copenia was diagnosed in 369 (30.6%) of women and 339 
(29.5%) of men. Table 1 demonstrates the baseline charac-
teristics of the participants by the status of osteosarcopenia 
in men and women. Age, BMI, physical activity, hypertri-
glyceridemia, high-fat mass, and education were signifi-
cantly different in participants with and without osteosarco-
penia in both sexes, and also the prevalence of hypertension 
and smoking status in women (all p-values < 0.05).
Figure 1 shows the prevalence of osteosarcopenia among 
four different age groups in men and women. As it high-
lights, in age below 75 years, the prevalence of osteosar-
copenia is higher in women, although the differences are 
not significant in all groups (p-values were 0.055, 0.178, 
and 0.049 in 60–64 years, 65–69, and 70–74 years, respec-
tively; however, among the oldest population (≥ 75 years), 
the prevalence was higher in men (59% vs. 48%, p-value 
0.015). In both sexes, the prevalence of osteosarcopenia 
increased by age, while the slope was higher in men (more 
than fourfold increase from 14.3% in aged 60–64 years 
to 59.4% in aged ≥ 75 years in men and more than two-
fold increase from 20.3% in aged 60–64 years to 48.3% in 
aged ≥ 75 years in women; p-interaction 0.019). The age-
standardized PR of osteosarcopenia in both sexes was nearly 
the same 33.8% (95% CI 31.0–36.5%) in men and 33.9% 
(95% CI 30.9–36.8%) in women.
Table 2 presents the results of the modified Poisson 
regression model to define the associate variables with 
osteosarcopenia. The best subset model includes BMI, 
high-fat mass, diabetes and education in both sexes, addi-
tional to the age and physical activity that were only sig-
nificant in men. BMI was inversely associated with oste-
osarcopenia, as having osteosacropenia was less likely 
with increasing BMI (PR 0.84, 95% CI 0.81–0.88 in men 
and PR 0.77, 95% CI 0.74–0.80 in women). Moreover, 
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each year of schooling was associated with a 3% lower 
prevalence of osteosarcopenia in men (PR 0.97, 95% CI 
0.95–0.99). Although the year of schooling showed the 
same association with osteosarcopenia in women, it was 
not statistically significant. Osteosarcopenia was less likely 
in men with physical activity (PR = 0.64, 95% CI 0.46, 
0.88) but no significant effect was detected in women. In 
both sexes, osteosarcopenia was more likely in individu-
als with high-fat mass (PR = 1.46, 95% CI 1.11–1.92) in 
men and (PR = 2.25, 95% CI 1.71–2.95) in women. Having 
osteosarcopenia was more likely in diabetic men (PR 1.33, 
95% CI 1.04–1.69), but not in women.
Discussion
Our study found a high prevalence of osteosarcopenia 
among a large sample of the elderly population. Though 
the difference between genders was not statistically sig-
nificant in all groups, the condition was more prevalent 
in women of all age categories, except among the oldest 
group (≥ 75 years), where it was more prevalent among 
men. Our findings primarily suggest that independent from 
gender, BMI has an inverse association with osteosarcope-
nia, whereas high-fat mass was directly linked to a nearly 
Table 1  Demographic characteristics of the participants by sex; Bushehr Elderly Health (BEH) program
p-values in bold indicate the significant results
Continuous variables shown as mean ± SD. Independent t-test and Pearson’s χ2 test were applied for quantitative and qualitative variables respec-
tively
a Median (IQR) categorical variables show as frequency (percent)
Continuous variables Osteosarcopenia+ Osteosarcopenia− p-value
Mean (95% CI) Mean (95% CI)
Women
 Age 71.2 (70.5–71.9) 68.3 (67.9–68.7)  < 0.001
 Body mass index 24.2 (23.9–24.6) 30.5 (30.2–30.8)  < 0.001
 Years of  schoolinga 0 (0–4.5) 2 (0–6)  < 0.001
Categorical variables N (%) N (%)
Women
 Diabetes mellitus 123 (33.3) 317 (38.0) 0.12
 Hypertension 257 (69.7) 649 (77.6) 0.003
 Current smoking 76 (21.2) 124 (15.1) 0.010
 Physical activity 69 (18.7) 208 (24.9) 0.019
 Low HDL 196 (53.1) 490 (58.6) 0.07
 Hypertriglyceridemia 95 (25.8) 318 (38.0)  < 0.001
 Hypercholesterolemia 152 (41.2) 321 (38.4) 0.36
 High-fat mass 234 (63.4) 705 (84.6)  < 0.001
Continuous variables Mean (SD) Mean (SD)
Men
 Age 73.3 (72.5–74.1) 67.9 (67.5–68.3)  < 0.001
 Body mass index 23.9 (23.6–24.3) 27.1 (26.9–27.4)  < 0.001
 Years of  schoolinga 6 (0–10) 8 (4–12)  < 0.001
Categorical variables N (%) N (%)
Men
 Diabetes mellitus 99 (29.3) 242 (30.0) 0.82
 Hypertension 236 (69.6) 573 (70.09) 0.66
 Current smoking 80 (24.1) 151 (19.4) 0.07
 Physical activity 46 (13.6) 223 (27.6)  < 0.001
 Low HDL 125 (36.9) 331 (40.9) 0.20
 Hypertriglyceridemia 76 (22.4) 252 (31.2) 0.003
 Hypercholesterolemia 82 (24.2) 207 (25.6) 0.61
 High-fat mass 181 (53.4) 518 (64.8)  < 0.001
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twofold increased prevalence of the condition, making it 
the strongest associated factor we evaluated.
The results of the present study were mainly in line with 
previous studies that had generally suggested endocrine 
metabolism dysfunctions such as obesity and diabetes, and 
also physical inactivity as factors influencing both muscle 
and bone status [28]. Another study on postmenopausal 
women showed the association of low skeletal muscle mass 
with metabolic syndrome, independent of other metabolic 
risk factors; as in the sarcopenia group, the odds of hav-
ing metabolic syndrome were nearly twice, compared to the 
normal group [29].
We found nearly 34% of our study population to be osteo-
sarcopenic. Previous studies on the prevalence of osteosar-
copenia as an independent condition among the elderly are 
few and consist of heterogeneous populations. A study on 
hip fracture patients in Korea reported a prevalence of 27.2% 
for osteosarcopenia [30], while studies on the German pre-
frail [31] and Australian [32] and Chinese [33] community-
dwelling elderly yielded prevalence rates of 28%, 40%, and 
13%, respectively.
Our study revealed that BMI and high-fat mass are inde-
pendently associated with the likelihood of osteosarco-
penia in both men and women. Some studies emphasized 
the importance of the independent role of BMI and waist 
circumference (WC) in clinical practice [34]. In our study, 
compared with WC, fat mass was a stronger associated vari-
able that remained in the model, independent of BMI. The 
protective role of greater BMI levels in association with the 
harmful effect of high-fat mass highlights the importance of 
lean muscle mass. The function of bone, muscle, and adi-
pose tissues are closely linked to one another via mechani-
cal and neuro-hormonal pathways. Any disturbance in these 
communication mechanisms could result in a simultaneous 
dysfunction in these tissues [35]. Moreover, studies have 
demonstrated that atrophied muscle and bone are replaced 
by adipose tissue in elderly osteosarcopenic patients [35, 
36]. These findings possibly explain why a higher level of 
BMI, with more lean muscle mass and less fat mass, reduces 
the risk of osteosarcopenia.
A higher proportion of muscle to fat mass has also been 
previously associated with a lower risk of cardio-metabolic 
and cardiovascular complications. For instance, in a sys-
tematic review of the literature, Gusmão-Sena et al. demon-
strated that “sarcopenic obesity” is linked with cardio-met-
abolic and CVDs as well as their risk factor [37]. Although 
their study was limited by the heterogeneous definitions 
for sarcopenic obesity that exist in the literature, they well 
revealed that coexisting of sarcopenia and high-fat mass 
is a risk factor worth further studying. Atkins et al. stud-
ied a cohort consisting of 4252 men aged 60–79 years and 
similarly found that sarcopenic obesity was associated with 
higher all-cause mortality [38]. In our study, we found diabe-
tes to be associated with osteosarcopenia in men. Although 
the association between diabetes and osteosarcopenia was 
not statistically significant, the magnitude of the PR was 
considerable (PR 1.22).
Though previous studies have revealed that type 1 DM 
can result in osteopenia/osteoporosis in adulthood, the link 
between type 2 DM and osteoporosis is not well recognized 
[39]. Although higher trabecular bone density has been 
reported in diabetic patients, cortical bone density is lower 
which results in low bone quality [40] and increased risk 
of fracture among diabetic patients. Regarding sarcopenia, 
insulin therapy in diabetes could cause weight gain [41]. 
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Fig. 1  Crude and age-standardized prevalence rates of osteosarcope-
nia in men and women; Bushehr Elderly Health (BEH) program
Table 2  Correlates of having osteosarcopenia in men and women; 
Bushehr Elderly Health (BEH) program
p-values in bold indicate the significant results
PR prevalence ratio, CI confidence interval
Adjusted PR (95% CI) p-value
Women
 Age – –
 Education 0.97 (0.95–1.00) 0.07
 Physical activity – –
 Diabetes 1.22 (0.97–1.52) 0.08
 Body mass index 0.77 (0.74–0.80)  < 0.001
 High-fat mass 2.25 (1.71–2.95)  < 0.001
Men
 Age 1.05 (1.04–1.07)  < 0.001
 Education 0.97 (0.95–0.99) 0.02
 Physical activity 0.64 (0.46–0.88) 0.006
 Diabetes 1.33 (1.04–1.69) 0.022
 Body mass index 0.84 (0.81–0.87)  < 0.001
 High-fat mass 1.46 (1.11–1.92) 0.007
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Furthermore, insulin resistance in these patients could result 
in accelerated muscle loss primarily because of metabolic 
and hormonal abnormalities [42]. These changes may make 
diabetic patients susceptible to osteosarcopenic obesity. 
However, current evidence cannot explain the different prev-
alence of osteosarcopenia between diabetic men and women. 
Since the evidence on the connection between diabetes and 
osteosarcopenia is lacking, further studies are needed.
We couldn’t find any association between osteosarcopenia 
and smoking and also lipid profiles.
Education was another factor to yield different results 
between men and women. We found that osteosarcopenia 
was less prevalent among educated elderly men. However, 
it did not statistically demonstrate a protective role against 
the condition in women. Theoretically, higher education is 
associated with a better lifestyle, including paying more 
attention to physical activity and a healthier diet compared 
with the less educated [43, 44]. Some unobserved determi-
nants of health behaviors may also be related to the educa-
tion. Almost half of the elderly women in our study popula-
tion had no education, resulting in less heterogeneity in this 
regard, which may explain the lack of association among 
women observed in this study.
Strengths and Limitations
This study with a large sample size from a population-based 
study supplied information on osteosarcopenia. Since oste-
osarcopenia is a newly-introduced condition, we did not 
come across many studies on osteosarcopenia in our search; 
instead, we found a handful of studies assessing the associa-
tion between cardio-metabolic risk factors and either osteo-
penia/osteoporosis or sarcopenia.
Our study showed a positive association between fat mass 
and osteosarcopenia; however like many other studies using 
DXA scan, we were unable to differentiate and quantify 
marrow adipose tissue, intermuscular adipose tissue, and 
intramuscular fat or intramyocellular lipid since DXA only 
quantifies lean mass [45]. Further studies using peripheral 
quantitative CT (pQCT), high resolution pQCT, magnetic 
resonance imaging (MRI), or peripheral MRI are needed 
to quantify ectopic fat and investigate its association with 
osteosarcopenia, independent of total body fat mass.
Since the osteosarcopenia consists of two different dis-
eases, the associations detected can be influenced by the 
both direction and power of the association of risk factor 
with each of disease components. Therefore, more studies 
should be performed to better understand the epidemiology 
and nature of this syndrome. Furthermore, as our study was 
a cross-sectional one, causal inferences cannot be made and 
further prospective studies are needed to clarify the underly-
ing causes.
Conclusions
Osteosarcopenia is a prevalent condition among a large pro-
portion of Iranian elderly population. Independent from gen-
der, BMI is inversely associated with osteosarcopenia, while 
high-fat mass is directly associated with the condition. Dia-
betes increased the prevalence of osteosarcopenia in men.
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